generic drug pricing

The U.S. Justice Department accused two generic pharmaceutical executives of colluding with each other to fix prices. According to a Bloomberg report, Jeffrey Glazer, the ex-CEO Heritage Pharmaceuticals, and Jason Malek, an ex-president of the company, were accused of conspiring with executives at...